Skip to main content
Log in

Cutaneous response to intradermal histamine in lung cancer

  • Allergy, Histamine and Kinins
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Recent evidence has suggested that human neoplastic patients show decreased blood histamine levels and cutaneous responses to intradermal histamine. In this study we evaluate the skin response to intradermal injections of histamine and IgE levels in 34 male patients with lung cancer (of which 21 had metastasis) and in 16 control subjects. Analysis of our data does not reveal any difference in the areas of wheal and flare between control subjects and lung cancer patients with or without metastasis. Moreover the evaluation of the different histologic cell type of lung cancer provides the same results. In addition, the sensitivity (Histamine Threshold Concentration) and reactivity (slopes) to histamine is not statistically different. No difference is found for IgE levels between controls and cancer patients. In the light of our finding we believe that in lung cancer patients skin response to intradermal histamine is not decreased and therefore that the hypothesis concerning the existence of H1-histamine receptor antagonist released by tumour is not confirmed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E. W. Fisherman,Does the allergic diathesis influence malignancy? J. Allergy31, 74–78 (1960).

    Google Scholar 

  2. K. J. Johnson,The relation of cancer to allergy. Lancet2, 5–11 (1966).

    Google Scholar 

  3. M. Alderson,Mortality from malignant disease in patients with asthma. Lancet2, 1475–1477 (1974).

    Google Scholar 

  4. R. M. Ford,Primary lung cancer and allergy. Ann. Allergy49, 240–242 (1978).

    Google Scholar 

  5. D. W. Cockcroft, G. H. Klein, R. E. Donevan and G. M. Copland,Is there a negative correlation between malignancy and respiratory atopy? Ann. Allergy43, 345–347 (1979).

    Google Scholar 

  6. J. E. Vena, J. R. Bona, T. E. Byers, E. Middleton, M. K. Swanson and S. Graham,Allergy-related diseases and cancer: an inverse association. Am. J. Epidemiol.122, 66–74 (1985).

    Google Scholar 

  7. H. H. McDuffie, D. W. Cockcroft, T. Ziallah, D. J. Klaassen and J. A. Dosman,Lower prevalence of positive atopic skin test in lung cancer patients. Chest2, 241–246 (1988).

    Google Scholar 

  8. J. Allegra, A. Lipton, H. Harvey, J. Luderer, D. Brenner, R. Mortel, L. Demers, M. Gillin, D. White and J. Trautlein,Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Cancer Res.36, 3225–3226 (1976).

    Google Scholar 

  9. W. D. McKee, C. A. Arnold and M. D. Perlman,A doubleblind study of the comparative incidence of malignancy and allergy. J. Allergy39, 294–301 (1967).

    Google Scholar 

  10. S. Shapiro, O. P. Heinonen and V. Siskind,Cancer and allergy. Cancer28, 396–401 (1971).

    Google Scholar 

  11. W. P. McWhorter,Allergy and risk of cancer. A prospective study using NHANESI follow-up data. Cancer62, 451–455 (1988).

    Google Scholar 

  12. C. D. Robinette and J. F. Fraumeni,Asthma and subsequent mortality in World War II veterans. J. Chron. Dis.31, 619–624 (1978).

    Google Scholar 

  13. J. Logan and D. Saker,The incidence of allergic disorders in cancer. N. Z. Med. J.52, 210–212 (1953).

    Google Scholar 

  14. C. E. Arbesman, J. I. Wypych and R. E. Reisman,Serum IgE in human diseases. InMechanisms in allergy, reagin-mediated hypersensitivity. pp. 153–176 (Ed. L. Goodfriend). M. Dekker, New York 1973.

    Google Scholar 

  15. T. A. Waldmann, J. M. Bull and R. M. Bruce,Serum immunoglobulin E levels in patients with neoplastic disease. J. Immunol.113, 379–383 (1974).

    Google Scholar 

  16. R. Augustin and K. D. Chandradasa,Circulating levels of IgE in patients with cancer. Lancet1, 102 (1973).

    Google Scholar 

  17. T. Blondal and E. Nou,Circulating IgE levels in patiens with bronchial carcinoma. Br. J. Dis. Chest.75, 77–82 (1981).

    Google Scholar 

  18. C. Burtin, P. Scheinmann, J. C. Salomon, G. Lespinats, F. Loisiller and P. Canu,The influence of intraperitoneal injections of histamine on tumor growth in fibrosarcoma bearing rats. Cancer Lett.12, 195 (1981).

    Google Scholar 

  19. C. Burtin, P. Scheinmann, J. C. Salomon, G. Lespinats, C. Frayssinet, B. Lebel and P. Canu,Increased tissue histamine in tumour-bearing mice and rats. Br. J. Cancer43, 684–688 (1981).

    Google Scholar 

  20. J. Bartholeyns and M. Bouclier,Involvement of histamine in growth of mouse and rat tumours: Antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res.44, 639–645 (1984).

    Google Scholar 

  21. D. MacKay, P. B. Marshall and J. F. Riley,Histidine decarboxylase activity in a malignant rat hepatoma. J. Physiol.31, 153–156 (1960).

    Google Scholar 

  22. C. Burtin, C. Noirot, C. Giroux and P. Scheinmann,Decreased skin response to intradermal histamine in cancer patients. J. Allergy Clin. Immunol.78, 83–89 (1986).

    Google Scholar 

  23. C. Burtin, C. Noirot, J. Paupe, and P. Scheinmann,Decreased blood histamine levels in patients with solid malignant tumours. Br. J. Cancer47, 367–372 (1983).

    Google Scholar 

  24. C. F. Mountain,A new international staging system for lung cancer. Chest89, 225S (1986).

    Google Scholar 

  25. L. H. Maurer, T. Pajak and W. Eaton,Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a phase III Cancer and Leukemia Group B study. J. Clin. Oncol.3, 969–976 (1985).

    Google Scholar 

  26. M. M. Oken, R. H. Creech and D. C. Thormey,Toxicity and response criteria of the Eastern Co-operative Oncology Group. Am. J. Clin. Oncol.5, 649–655 (1982).

    Google Scholar 

  27. A. P. Simoplos and T. B. Van Itallie,Body weight, health and longevity. Ann. Int. Med.100, 285–295 (1984).

    Google Scholar 

  28. L. Marazzini, M. Bozzoni, B. Mastropasqua, A. Pelucchi and M. Gabrione,The effect of adrenoceptor agonists and antagonists on histamine-induced wheal response in the skin of normal subjects and atopic patients. Ann. Allergy60, 407–410 (1988).

    Google Scholar 

  29. S. A. Glantz,Primer of Biostatistics. McGraw-Hill, New York 1988.

    Google Scholar 

  30. G. Khalson and E. Rosengren,Biogenesis and physiology of histamine. Edward Arnold, London 1971.

    Google Scholar 

  31. M. Osband, Y. S. Shen, M. Schlesinger, A. Brown, D. Hamilton, E. Cohen, P. Lavin and R. McCaffrey,Successful tumor immunotherapy with cimetidine in mice. Lancet1, 636–638 (1981).

    Google Scholar 

  32. C. Burtin, P. Scheimann, J. C. Salomon, G. Lespinats and P. Canu,Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H 1 and H 2 histamine receptors. Br. J. Cancer45, 54–60 (1982).

    Google Scholar 

  33. R. M. Agius, R. C. Godfrey and S. T. Holgate,Mast cell and histamine content of human bronchoalveolar lavage fluid. Thorax40, 760–767 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cavigioli, G., Mastropasqua, B., Pelucchi, A. et al. Cutaneous response to intradermal histamine in lung cancer. Agents and Actions 34, 309–315 (1991). https://doi.org/10.1007/BF01988721

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01988721

Keywords

Navigation